{"id": "0", "input": "Glaxo aims high after profit fall  GlaxoSmithKline saw its profits fall 9% last year to £6.2bn ($11.5bn), but Europe biggest drugmaker says a recovery during 2005 is on the way.", "nodes": [{"id": 0, "label": "company"}, {"id": 1, "label": "aim-01"}, {"id": 2, "label": "high-02"}, {"id": 3, "label": "after"}, {"id": 4, "label": "profit-01"}, {"id": 5, "label": "fall-01"}, {"id": 6, "label": "company"}, {"id": 7, "label": "see-01"}, {"id": 8, "label": "profit-01"}, {"id": 9, "label": "fall-01"}, {"id": 10, "label": "percentage-entity", "properties": ["value"], "values": ["9"]}, {"id": 11, "label": "last"}, {"id": 12, "label": "year"}, {"id": 13, "label": "pound"}, {"id": 14, "label": "monetary-quantity", "properties": ["quant"], "values": ["<none>"]}, {"id": 15, "label": "have-concession-91"}, {"id": 16, "label": "continent"}, {"id": 17, "label": "big"}, {"id": 18, "label": "most"}, {"id": 19, "label": "have-degree-91"}, {"id": 20, "label": "drug"}, {"id": 21, "label": "make-01"}, {"id": 22, "label": "say-01"}, {"id": 23, "label": "name", "properties": ["op1"], "values": ["europe"]}, {"id": 24, "label": "recover-01"}, {"id": 25, "label": "date-entity", "properties": ["year"], "values": ["2005"]}, {"id": 26, "label": "name", "properties": ["op1"], "values": ["glaxosmithkline"]}, {"id": 27, "label": "way"}, {"id": 28, "label": "name", "properties": ["op1"], "values": ["glaxo"]}], "edges": [{"source": 0, "target": 28, "label": "name"}, {"source": 19, "target": 18, "label": "arg3"}, {"source": 14, "target": 13, "label": "unit"}, {"source": 1, "target": 0, "label": "arg0"}, {"source": 19, "target": 17, "label": "arg2"}, {"source": 6, "target": 26, "label": "name"}, {"source": 11, "target": 12, "label": "domain"}, {"source": 24, "target": 25, "label": "time"}, {"source": 16, "target": 23, "label": "name"}, {"source": 15, "target": 22, "label": "arg1"}, {"source": 15, "target": 7, "label": "arg2"}, {"source": 15, "target": 1, "label": "arg2"}, {"source": 7, "target": 6, "label": "arg0"}, {"source": 21, "target": 20, "label": "arg1"}, {"source": 8, "target": 0, "label": "arg0"}, {"source": 9, "target": 14, "label": "arg4"}, {"source": 1, "target": 2, "label": "arg1"}, {"source": 8, "target": 6, "label": "arg0"}, {"source": 9, "target": 10, "label": "arg2"}, {"source": 22, "target": 24, "label": "arg1"}, {"source": 7, "target": 9, "label": "arg1"}, {"source": 5, "target": 4, "label": "arg1"}, {"source": 5, "target": 8, "label": "arg1"}, {"source": 19, "target": 16, "label": "arg5"}, {"source": 9, "target": 12, "label": "time"}, {"source": 3, "target": 5, "label": "op1"}, {"source": 21, "target": 0, "label": "arg1"}, {"source": 22, "target": 27, "label": "arg1"}], "tops": [15], "framework": "amr", "time": "2025-04-12"}
{"id": "1", "input": "Cheap copies of its drugs, particularly anti-depressants Paxil and Wellbutrin, and a weak dollar had hit profits, but global sales were up 1% in 2004.", "nodes": [{"id": 0, "label": "cheap-02"}, {"id": 1, "label": "copy-01"}, {"id": 2, "label": "it"}, {"id": 3, "label": "drug"}, {"id": 4, "label": "particular"}, {"id": 5, "label": "counter-01"}, {"id": 6, "label": "product"}, {"id": 7, "label": "name", "properties": ["op1"], "values": ["wellbutrin"]}, {"id": 8, "label": "and"}, {"id": 9, "label": "product"}, {"id": 10, "label": "and"}, {"id": 11, "label": "weak-02"}, {"id": 12, "label": "dollar"}, {"id": 13, "label": "hit-02"}, {"id": 14, "label": "profit-01"}, {"id": 15, "label": "contrast-01"}, {"id": 16, "label": "globe"}, {"id": 17, "label": "sell-01"}, {"id": 18, "label": "up-02"}, {"id": 19, "label": "percentage-entity", "properties": ["value"], "values": ["1"]}, {"id": 20, "label": "date-entity", "properties": ["year"], "values": ["2004"]}, {"id": 21, "label": "name", "properties": ["op1"], "values": ["paxil"]}], "edges": [{"source": 11, "target": 12, "label": "arg1"}, {"source": 18, "target": 19, "label": "arg2"}, {"source": 13, "target": 14, "label": "arg1"}, {"source": 15, "target": 13, "label": "arg1"}, {"source": 15, "target": 18, "label": "arg2"}, {"source": 18, "target": 20, "label": "time"}, {"source": 18, "target": 17, "label": "arg1"}, {"source": 1, "target": 3, "label": "arg1"}, {"source": 9, "target": 7, "label": "name"}, {"source": 13, "target": 12, "label": "arg0"}, {"source": 6, "target": 21, "label": "name"}, {"source": 8, "target": 9, "label": "op2"}, {"source": 16, "target": 17, "label": "domain"}, {"source": 8, "target": 6, "label": "op1"}, {"source": 10, "target": 12, "label": "op2"}, {"source": 1, "target": 2, "label": "arg0"}, {"source": 10, "target": 6, "label": "op1"}, {"source": 10, "target": 1, "label": "op1"}, {"source": 4, "target": 6, "label": "domain"}, {"source": 5, "target": 3, "label": "arg0"}, {"source": 1, "target": 0, "label": "arg1"}], "tops": [15], "framework": "amr", "time": "2025-04-12"}
{"id": "2", "input": "The firm is confident its new drug pipeline will deliver profits despite the failure of an obesity drug.", "nodes": [{"id": 0, "label": "firm"}, {"id": 1, "label": "confident-01"}, {"id": 2, "label": "new-01"}, {"id": 3, "label": "drug"}, {"id": 4, "label": "pipeline"}, {"id": 5, "label": "deliver-01"}, {"id": 6, "label": "profit-01"}, {"id": 7, "label": "fail-01"}, {"id": 8, "label": "obesity"}, {"id": 9, "label": "drug"}], "edges": [{"source": 2, "target": 4, "label": "arg1"}, {"source": 5, "target": 7, "label": "concession"}, {"source": 5, "target": 6, "label": "arg1"}, {"source": 1, "target": 5, "label": "arg2"}, {"source": 5, "target": 4, "label": "arg0"}, {"source": 1, "target": 0, "label": "arg1"}, {"source": 7, "target": 9, "label": "arg1"}, {"source": 8, "target": 9, "label": "domain"}, {"source": 4, "target": 0, "label": "poss"}], "tops": [1], "framework": "amr", "time": "2025-04-12"}
{"id": "3", "input": "Chief executive Jean-Pierre Garnier said it had been a \"difficult year\".", "nodes": [{"id": 0, "label": "chief"}, {"id": 1, "label": "executive"}, {"id": 2, "label": "say-01"}, {"id": 3, "label": "difficult"}, {"id": 4, "label": "year"}, {"id": 5, "label": "person"}, {"id": 6, "label": "have-org-role-91"}, {"id": 7, "label": "name", "properties": ["op1", "op2"], "values": ["jean-pierre", "garnier"]}], "edges": [{"source": 5, "target": 7, "label": "name"}, {"source": 6, "target": 5, "label": "arg0"}, {"source": 0, "target": 1, "label": "domain"}, {"source": 2, "target": 5, "label": "arg0"}, {"source": 6, "target": 1, "label": "arg2"}, {"source": 3, "target": 4, "label": "domain"}, {"source": 2, "target": 4, "label": "arg1"}], "tops": [2], "framework": "amr", "time": "2025-04-12"}
{"id": "4", "input": "In early afternoon trade in London the company share price was down 1% at 1218 pence.", "nodes": [{"id": 0, "label": "early"}, {"id": 1, "label": "date-entity"}, {"id": 2, "label": "afternoon"}, {"id": 3, "label": "trade-01"}, {"id": 4, "label": "city"}, {"id": 5, "label": "company"}, {"id": 6, "label": "share"}, {"id": 7, "label": "price-01"}, {"id": 8, "label": "down-03"}, {"id": 9, "label": "percentage-entity", "properties": ["value"], "values": ["1"]}, {"id": 10, "label": "monetary-quantity", "properties": ["quant"], "values": ["1218"]}, {"id": 11, "label": "penny"}, {"id": 12, "label": "name", "properties": ["op1"], "values": ["london"]}], "edges": [{"source": 4, "target": 12, "label": "name"}, {"source": 1, "target": 2, "label": "dayperiod"}, {"source": 0, "target": 1, "label": "op1"}, {"source": 10, "target": 11, "label": "unit"}, {"source": 8, "target": 3, "label": "time"}, {"source": 8, "target": 9, "label": "quant"}, {"source": 7, "target": 6, "label": "arg1"}, {"source": 3, "target": 4, "label": "location"}, {"source": 8, "target": 7, "label": "arg1"}, {"source": 6, "target": 5, "label": "poss"}, {"source": 7, "target": 5, "label": "arg1"}, {"source": 3, "target": 1, "label": "time"}], "tops": [8], "framework": "amr", "time": "2025-04-12"}
{"id": "5", "input": "Mr Garnier said the company had absorbed over £1.5bn of lost sales to generics but still managing to grow the business.", "nodes": [{"id": 0, "label": "say-01"}, {"id": 1, "label": "company"}, {"id": 2, "label": "absorb-01"}, {"id": 3, "label": "over"}, {"id": 4, "label": "pound"}, {"id": 5, "label": "monetary-quantity", "properties": ["quant"], "values": ["<none>"]}, {"id": 6, "label": "lose-02"}, {"id": 7, "label": "sell-01"}, {"id": 8, "label": "generic"}, {"id": 9, "label": "have-concession-91"}, {"id": 10, "label": "still"}, {"id": 11, "label": "manage-01"}, {"id": 12, "label": "grow-01"}, {"id": 13, "label": "thing"}, {"id": 14, "label": "business"}, {"id": 15, "label": "person"}, {"id": 16, "label": "name", "properties": ["op1", "op2"], "values": ["mr", "garnier"]}], "edges": [{"source": 15, "target": 16, "label": "name"}, {"source": 5, "target": 4, "label": "unit"}, {"source": 0, "target": 15, "label": "arg0"}, {"source": 3, "target": 5, "label": "op1"}, {"source": 12, "target": 14, "label": "arg1"}, {"source": 11, "target": 12, "label": "arg1"}, {"source": 10, "target": 11, "label": "domain"}, {"source": 0, "target": 9, "label": "arg1"}, {"source": 9, "target": 11, "label": "arg1"}, {"source": 6, "target": 13, "label": "arg1"}, {"source": 2, "target": 3, "label": "arg1"}, {"source": 7, "target": 13, "label": "arg1"}, {"source": 2, "target": 1, "label": "arg0"}, {"source": 9, "target": 2, "label": "arg2"}, {"source": 2, "target": 13, "label": "arg1"}, {"source": 11, "target": 1, "label": "arg0"}, {"source": 2, "target": 8, "label": "arg0"}, {"source": 12, "target": 1, "label": "arg0"}], "tops": [0], "framework": "amr", "time": "2025-04-12"}
{"id": "6", "input": "\"The continuing success of our key products means we can now look forward to a good performance in 2005,\" he said.", "nodes": [{"id": 0, "label": "continue-01"}, {"id": 1, "label": "succeed-01"}, {"id": 2, "label": "wur"}, {"id": 3, "label": "key-02"}, {"id": 4, "label": "product"}, {"id": 5, "label": "mean-01"}, {"id": 6, "label": "possible-01"}, {"id": 7, "label": "now"}, {"id": 8, "label": "look-forward-03"}, {"id": 9, "label": "good-02"}, {"id": 10, "label": "perform-02"}, {"id": 11, "label": "date-entity", "properties": ["year"], "values": ["2005"]}, {"id": 12, "label": "he"}, {"id": 13, "label": "say-01"}], "edges": [{"source": 3, "target": 4, "label": "arg1"}, {"source": 5, "target": 6, "label": "arg2"}, {"source": 13, "target": 12, "label": "arg0"}, {"source": 5, "target": 1, "label": "arg1"}, {"source": 0, "target": 1, "label": "arg1"}, {"source": 4, "target": 2, "label": "poss"}, {"source": 1, "target": 4, "label": "arg1"}, {"source": 13, "target": 5, "label": "arg1"}, {"source": 9, "target": 10, "label": "arg1"}, {"source": 8, "target": 10, "label": "arg1"}, {"source": 8, "target": 2, "label": "arg0"}, {"source": 10, "target": 11, "label": "time"}, {"source": 6, "target": 8, "label": "arg1"}, {"source": 10, "target": 2, "label": "arg0"}], "tops": [13], "framework": "amr", "time": "2025-04-12"}
{"id": "7", "input": "\"2005 will also be an important year in terms of research and development pipeline progress.\"", "nodes": [{"id": 0, "label": "date-entity", "properties": ["year"], "values": ["2005"]}, {"id": 1, "label": "also"}, {"id": 2, "label": "important-01"}, {"id": 3, "label": "research-01"}, {"id": 4, "label": "and"}, {"id": 5, "label": "develop-02"}, {"id": 6, "label": "pipeline"}, {"id": 7, "label": "progress-01"}], "edges": [{"source": 2, "target": 7, "label": "arg1"}, {"source": 5, "target": 6, "label": "arg1"}, {"source": 4, "target": 5, "label": "op2"}, {"source": 3, "target": 6, "label": "domain"}, {"source": 1, "target": 2, "label": "domain"}, {"source": 7, "target": 4, "label": "arg1"}, {"source": 4, "target": 3, "label": "op1"}], "tops": [2], "framework": "amr", "time": "2025-04-12"}
{"id": "8", "input": "However, the firm discontinued development of an experimental treatment for obesity, known as 771, after disappointing clinical trial results.", "nodes": [{"id": 0, "label": "have-concession-91"}, {"id": 1, "label": "thing"}, {"id": 2, "label": "firm"}, {"id": 3, "label": "discontinue-01"}, {"id": 4, "label": "develop-02"}, {"id": 5, "label": "experiment-01"}, {"id": 6, "label": "treat-03"}, {"id": 7, "label": "obesity"}, {"id": 8, "label": "know-02", "properties": ["arg2"], "values": ["771"]}, {"id": 9, "label": "after"}, {"id": 10, "label": "disappoint-01"}, {"id": 11, "label": "clinic"}, {"id": 12, "label": "result-01"}], "edges": [{"source": 6, "target": 7, "label": "arg2"}, {"source": 0, "target": 3, "label": "arg2"}, {"source": 3, "target": 9, "label": "time"}, {"source": 3, "target": 2, "label": "arg0"}, {"source": 4, "target": 6, "label": "arg1"}, {"source": 3, "target": 4, "label": "arg1"}, {"source": 10, "target": 2, "label": "arg0"}, {"source": 9, "target": 10, "label": "op1"}, {"source": 10, "target": 1, "label": "arg1"}, {"source": 12, "target": 1, "label": "arg2"}, {"source": 5, "target": 6, "label": "domain"}, {"source": 3, "target": 10, "label": "time"}, {"source": 8, "target": 6, "label": "arg1"}, {"source": 10, "target": 4, "label": "arg1"}, {"source": 8, "target": 7, "label": "arg2"}], "tops": [0], "framework": "amr", "time": "2025-04-12"}
{"id": "9", "input": "Glaxo is relying on new treatments for conditions such as cancer, diabetes, depression, HIV/AIDS and allergies to lift the pace of sales growth after several disappointing years.", "nodes": [{"id": 0, "label": "company"}, {"id": 1, "label": "rely-01"}, {"id": 2, "label": "new-01"}, {"id": 3, "label": "treat-03"}, {"id": 4, "label": "condition"}, {"id": 5, "label": "disease"}, {"id": 6, "label": "name", "properties": ["op1", "op1"], "values": ["cancer", "diabetes"]}, {"id": 7, "label": "disease"}, {"id": 8, "label": "depress-01"}, {"id": 9, "label": "name"}, {"id": 10, "label": "disease"}, {"id": 11, "label": "and"}, {"id": 12, "label": "allergy"}, {"id": 13, "label": "lift-01"}, {"id": 14, "label": "name", "properties": ["op1"], "values": ["hiv/aids"]}, {"id": 15, "label": "pace-01"}, {"id": 16, "label": "sell-01"}, {"id": 17, "label": "grow-01"}, {"id": 18, "label": "after"}, {"id": 19, "label": "temporal-quantity", "properties": ["quant"], "values": ["1"]}, {"id": 20, "label": "several"}, {"id": 21, "label": "disappoint-01"}, {"id": 22, "label": "year"}, {"id": 23, "label": "person"}, {"id": 24, "label": "name", "properties": ["op1"], "values": ["glaxo"]}], "edges": [{"source": 0, "target": 24, "label": "name"}, {"source": 20, "target": 19, "label": "op1"}, {"source": 19, "target": 22, "label": "unit"}, {"source": 1, "target": 0, "label": "arg0"}, {"source": 17, "target": 16, "label": "arg1"}, {"source": 1, "target": 3, "label": "arg1"}, {"source": 23, "target": 24, "label": "name"}, {"source": 15, "target": 17, "label": "arg1"}, {"source": 11, "target": 12, "label": "op4"}, {"source": 1, "target": 13, "label": "purpose"}, {"source": 11, "target": 8, "label": "op4"}, {"source": 11, "target": 7, "label": "op2"}, {"source": 13, "target": 23, "label": "arg0"}, {"source": 13, "target": 15, "label": "arg1"}, {"source": 1, "target": 18, "label": "time"}, {"source": 11, "target": 5, "label": "op1"}, {"source": 1, "target": 23, "label": "arg0"}, {"source": 11, "target": 10, "label": "op4"}, {"source": 3, "target": 4, "label": "arg2"}, {"source": 2, "target": 3, "label": "arg1"}, {"source": 4, "target": 11, "label": "example"}, {"source": 10, "target": 14, "label": "name"}, {"source": 5, "target": 6, "label": "name"}, {"source": 7, "target": 6, "label": "name"}, {"source": 18, "target": 20, "label": "quant"}, {"source": 13, "target": 0, "label": "arg0"}], "tops": [1], "framework": "amr", "time": "2025-04-12"}
